Free Trial

United Therapeutics (UTHR) Earnings Date, Estimates & Call Transcripts

United Therapeutics logo
$294.60 +0.75 (+0.26%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$290.16 -4.44 (-1.51%)
As of 09:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United Therapeutics Earnings Summary

Latest Q1
Earnings Date
Apr. 30Estimated
Consensus EPS
(Apr. 30)
$6.29
Actual EPS
(Apr. 30)
$6.63 Beat By $0.34
Actual Revenue
(Apr. 30)
$794.40M

United Therapeutics posted Q1 2025 earnings on April 30, 2025, reporting an EPS of $6.63, which topped the consensus estimate of $6.29 by $0.34. Quarterly revenue rose 17.2% year-over-year to $794.40 million, above analysts' expectations of $726.82 million. With a trailing EPS of $25.06 and a P/E Ratio of 12.94, United Therapeutics' earnings are expected to grow 12.30% next year, from $24.48 to $27.49 per share.

Q1 2025 Earnings Resources

Get United Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on United Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

UTHR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

UTHR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

United Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253$6.36$7.07$6.64
Q2 20253$6.71$7.39$7.10
Q3 20253$6.95$8.08$7.45
Q4 20253$6.68$7.82$7.13
FY 2025 12 $26.70 $30.36 $28.32
Q1 20261$6.48$6.48$6.48
Q2 20261$6.76$6.76$6.76
Q3 20261$7.12$7.12$7.12
Q4 20261$7.36$7.36$7.36

United Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/30/2025Q1 2025$6.29$6.63+$0.34$6.63$726.82M$794.40M
2/26/2025Q4 2024$6.10$6.19+$0.09$6.19$734.74M$735.90M
10/30/2024Q3 2024$6.16$6.39+$0.23$6.39$722.62M$748.90M
7/31/2024Q2 2024$6.33$5.85 -$0.48$5.85$691.87M$714.90M
5/1/2024Q1 2024$5.63$6.17+$0.54$6.17$620.31M$677.70M
2/21/2024Q4 2023$4.28$4.36+$0.08$4.36$575.01M$614.70M
11/1/2023Q3 2023$5.10$5.38+$0.28$5.38$585.82M$609.40M
8/2/2023Q2 2023$4.57$5.24+$0.67$5.24$524.18M$596.50M

United Therapeutics Earnings - Frequently Asked Questions

United Therapeutics (NASDAQ:UTHR) last announced its quarterly earning data on Wednesday, April 30, 2025. Learn more on UTHR's earnings history.

In the previous quarter, United Therapeutics (NASDAQ:UTHR) reported $6.63 earnings per share (EPS) to beat the analysts' consensus estimate of $6.29 by $0.34. Learn more on analysts' earnings estimate vs. UTHR's actual earnings.

The conference call for United Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for United Therapeutics's latest earnings report can be read online.
Read Transcript

United Therapeutics's earnings report can be found in their filing with the SEC.
View SEC filing

United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $2.99 billion.

United Therapeutics (NASDAQ:UTHR) has a recorded net income of $984.80 million. UTHR has generated $25.06 earnings per share over the last four quarters.

United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 12.94 and a forward price-to-earnings ratio of 12.03. The price/earnings-to-growth ratio is 0.97.

United Therapeutics's earnings are expected to grow from $24.48 per share to $27.49 per share in the next year, which is a 12.30% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:UTHR) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners